Articles tagged "Waiting lists"

2019 American Transplant Congress
Management of Inactive Candidates on the Kidney Transplant Waitlist: Results from a National Survey
J. Hiller, J. Chen, K. Covarrubias, K. Jackson, J. Long, S. DiBrito, D. Segev, J. Garonzik Wang
Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: As the inactive deceased donor kidney transplant (DDKT) waitlist pool continues to grow, management of these patients has become an increasingly complex administrative undertaking.…
2019 American Transplant Congress
Impact of MELD-Na Course (Delta MELD-Na) on Outcome after Liver Transplantation
G. Silberhumer¹, G. Gyoeri¹, L. Unger², G. Harpain¹
¹Transplant Surgery, Medical University Vienna, Vienna, Austria, ²Institute for Mathematics and Bioscience, Medical University Vienna, Vienna, Austria
*Purpose: Currently, MELD Score listing is state of the art for liver transplant recipients. Our department could show by our own institutional data and confirmed…
2019 American Transplant Congress
Real World Impact of HCV Viremic Solid Organs on Waitlist Times
N. Kapila¹, A. Ur Rahman¹, K. Gupta², K. Al Khalloufi³, E. Navas³, D. Reino³, S. Ebaid³, N. Agarwal³, J. Shaw³, C. Murgas³, S. Rhazouani³, A. Zeeshan³, A. Tzakis³, C. Sheffield³, J. Vanatta³, X. Zervos³
¹Gastroenterology and Hepatology, Cleveland Clinic Florida, Weston, FL, ²Internal Medicine, University of Miami/JFK Consortium, Atlantis, FL, ³Transplant, Cleveland Clinic Florida, Weston, FL
*Purpose: The advent of direct acting antiviral agents (DAAs) has led to a paradigm shift in the approach to hepatitis C (HCV) infected organs. The…
2019 American Transplant Congress
Impact of Race and Substance Use on Listing Decisions for Kidney Transplant
R. N. DeBlasio¹, L. Myaskovsky², K. Kendall¹, A. DiMartini¹, G. Switzer¹, D. M. Posluszny¹, C. Puttarajappa¹, A. D. Tevar¹, S. Hariharan¹, R. Shapiro³, M. A. Dew¹
¹U Pittsburgh, Pittsburgh, PA, ²U New Mexico, Albuquerque, NM, ³Mt Sinai Recanati/Miller Transplantation Institute, New York, NY
*Purpose: Racial/ethnic minority patients face reduced access to kidney transplantation. We hypothesized that this disparity may be magnified if patients also have major psychosocial liabilities…
2019 American Transplant Congress
Temporal Trends of First-Year Mortality on the Adult Kidney-Only Wait List in the United States
F. Tedla, A. Gruessner, I. Puri, A. Brar, N. Sumrani, D. John, J. Renz, R. Gruessner, M. Salifu
SUNY Downstate Medical Center, Brooklyn, NY
*Purpose: Evaluation of kidney transplant candidacy must balance risk of mortality with and without transplant. Trends in first-year mortality could inform patterns of risk avoidance…
2019 American Transplant Congress
Use, Safety and Effectiveness of Hepatitis B Virus NAT-Positive Donor Livers in the Current Era
T. C. Lee, K. Safdar, L. K. Winer, M. C. Morris, A. Kassam, K. Luckett, R. Quillin III, K. Bari, N. Anwar, S. A. Shah
University of Cincinnati, Cincinnati, OH
*Purpose: The use of hepatitis B (HBV) core antibody positive (HBcAb+) donor allografts in liver transplantation (OLT) has become accepted practice; however, given limited data…
2019 American Transplant Congress
Pancreas Allograft Importation Should Be Fostered by Any Transplant Center Challenged by Excessively Long Waitlist Times
J. Torabi, J. P. Rocca, L. Lirano, Y. Azzizi, M. Ajaimy, C. Pynadath, E. Akalin, M. Kinkhabwala, J. A. Graham
Montefiore Medical Center, Bronx, NY
*Purpose: Pancreas transplantation is a durable option for patients with insulin dependent diabetes. However, geographic inequity has created a supply side problem for our region.…
2019 American Transplant Congress
Access To The Kidney Transplant Waitlist For Patients With Hiv And End-stage Renal Disease
A. A. Shaffer¹, H. Ying², N. Chu¹, A. G. Thomas³, C. Haugen², S. Norman⁴, D. L. Segev¹, M. A. McAdams-DeMarco¹
¹Surgery & Epidemiology, Johns Hopkins University, Baltimore, MD, ²Surgery, Johns Hopkins University, Baltimore, MD, ³Epidemiology, University of North Carolina, Chapel Hill, NC, ⁴Surgery, University of Michigan, Ann Arbor, MI
*Purpose: Patients with HIV and end-stage renal disease (ESRD) experience higher mortality on dialysis than those without HIV. These HIV+ dialysis patients may face barriers…
2019 American Transplant Congress
Effect of Human Leukocytic Antigen Matching on Clinical Outcomes after Deceased Donor Renal Allograft Transplant: A Single Centre Experience
M. E. Gramlick¹, M. K. Heer², S. Yausis², P. R. Trevillian²
¹Department of Surgery, John Hunter Hospital, Newcastle, Australia, ²Newcastle Transplant Unit, John Hunter Hospital, Newcastle, Australia
*Purpose: Human leucocyte antigen (HLA) matching has been the cornerstone of kidney allocation policies. With increasing expertise in assessing and managing immunological risks, the impact…
2019 American Transplant Congress
MELD-Na Alterations on the Liver Transplant Waiting List and Its Impact on Listing Outcome
G. Silberhumer¹, G. Gyoeri¹, L. Baumann¹, S. Zehetmayer², T. Soliman¹, G. Berlakovich¹
¹Transplant Surgery, Medical University Vienna, Vienna, Austria, ²Statistics Department, Medical University Vienna, Vienna, Austria
*Purpose: Currently, MELD Score listing is state of the art for liver transplant recipients. Our department could show by our own data and confirmed by…